First Time Loading...

Histogen Inc
NASDAQ:HSTO

Watchlist Manager
Histogen Inc Logo
Histogen Inc
NASDAQ:HSTO
Watchlist
Price: 0.15 USD -25% Market Closed
Updated: May 4, 2024

Histogen Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Histogen Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Histogen Inc
NASDAQ:HSTO
Revenue
$30k
CAGR 3-Years
N/A
CAGR 5-Years
-76%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

Histogen Inc
Revenue Breakdown

Breakdown by Geography
Histogen Inc

Not Available

Breakdown by Segments
Histogen Inc

Total Revenue: 3.8m USD
100%
License: 3.8m USD
100.8%

See Also

What is Histogen Inc's Revenue?
Revenue
30k USD

Based on the financial report for Sep 30, 2023, Histogen Inc's Revenue amounts to 30k USD.

What is Histogen Inc's Revenue growth rate?
Revenue CAGR 5Y
-76%

Over the last year, the Revenue growth was -99%.